Ardelyx's (ARDX) Shares Plunge as Tenapanor's Deficiencies Identified by FDA 'Take Approval Off the Table'
Go back to Ardelyx's (ARDX) Shares Plunge as Tenapanor's Deficiencies Identified by FDA 'Take Approval Off the Table'| Oppenheimer Rising Dividends Fund, Inc. Class A (NASDAQ: ARDX) | Delayed: 5.69 -0.1 (1.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.79 | 52 Week High | $20.98 | |||
| Open | $5.80 | 52 Week Low | $6.36 | |||
| Day High | $5.90 | P/E | N/A | |||
| Day Low | $5.68 | EPS | $0.00 | |||
| Volume | 2,628,460 | |||||
